275 related articles for article (PubMed ID: 15328084)
1. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
Vanden Bossche H; Ausma J; Bohets H; Vermuyten K; Willemsens G; Marichal P; Meerpoel L; Odds F; Borgers M
Antimicrob Agents Chemother; 2004 Sep; 48(9):3272-8. PubMed ID: 15328084
[TBL] [Abstract][Full Text] [Related]
2. Saperconazole: a selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes.
Vanden Bossche H; Marichal P; Willemsens G; Bellens D; Gorrens J; Roels I; Coene MC; Le Jeune L; Janssen PA
Mycoses; 1990; 33(7-8):335-52. PubMed ID: 2090934
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of the novel azole antifungal agent r126638.
Odds F; Ausma J; Van Gerven F; Woestenborghs F; Meerpoel L; Heeres J; Vanden Bossche H; Borgers M
Antimicrob Agents Chemother; 2004 Feb; 48(2):388-91. PubMed ID: 14742185
[TBL] [Abstract][Full Text] [Related]
4. Activity of the triazole antifungal r126638 as assessed by corneofungimetry.
Piérard-Franchimont C; Ausma J; Wouters L; Vroome V; Vandeplassche L; Borgers M; Cauwenbergh G; Piérard GE
Skin Pharmacol Physiol; 2006; 19(1):50-6. PubMed ID: 16247249
[TBL] [Abstract][Full Text] [Related]
5. Biochemical mode of action and enantiomeric selectivity of SDZ 89-485, a new triazole antimycotic.
Ryder NS
J Med Vet Mycol; 1990; 28(5):385-94. PubMed ID: 2283585
[TBL] [Abstract][Full Text] [Related]
6. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole.
Berg D; Regel E; Harenberg HE; Plempel M
Arzneimittelforschung; 1984; 34(2):139-46. PubMed ID: 6372801
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of efinaconazole, a novel triazole antifungal agent.
Tatsumi Y; Nagashima M; Shibanushi T; Iwata A; Kangawa Y; Inui F; Siu WJ; Pillai R; Nishiyama Y
Antimicrob Agents Chemother; 2013 May; 57(5):2405-9. PubMed ID: 23459486
[TBL] [Abstract][Full Text] [Related]
8. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
Morita T; Nozawa Y
J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation the antimycotic activity of itraconazole in human stratum corneum with vitro fungi cultivation].
Xu W; Zhao JY; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):530-3. PubMed ID: 15949332
[TBL] [Abstract][Full Text] [Related]
10. Biochemical changes associated with the antifungal action of the triazole ICI 153,066 on Candida albicans and Trichophyton quinckeanum.
Barrett-Bee K; Newboult L; Pinder P
FEMS Microbiol Lett; 1991 Apr; 63(2-3):127-31. PubMed ID: 2060756
[TBL] [Abstract][Full Text] [Related]
11. Linalool modulates dermatophyte susceptibility to azole drugs.
Ponte HAS; Lima MIO; Lima EO; Pereira FO
Med Mycol; 2020 Feb; 58(2):272-274. PubMed ID: 31329906
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.
Marichal P; Gorrens J; Laurijssens L; Vermuyten K; Van Hove C; Le Jeune L; Verhasselt P; Sanglard D; Borgers M; Ramaekers FC; Odds F; Vanden Bossche H
Antimicrob Agents Chemother; 1999 Nov; 43(11):2663-70. PubMed ID: 10543744
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of R126638 and ketoconazole against Malassezia species.
Faergemann J; Ausma J; Borgers M
Acta Derm Venereol; 2006; 86(4):312-5. PubMed ID: 16874415
[TBL] [Abstract][Full Text] [Related]
14. In vitro analysis of itraconazole cis-diastereoisomers inhibition of nine cytochrome P450 enzymes: stereoselective inhibition of CYP3A.
Krasulova K; Dvorak Z; Anzenbacher P
Xenobiotica; 2019 Jan; 49(1):36-42. PubMed ID: 29320899
[TBL] [Abstract][Full Text] [Related]
15. The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.
Warrilow AGS; Parker JE; Price CL; Garvey EP; Hoekstra WJ; Schotzinger RJ; Wiederhold NP; Nes WD; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483956
[TBL] [Abstract][Full Text] [Related]
16. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages.
Hart DT; Lauwers WJ; Willemsens G; Vanden Bossche H; Opperdoes FR
Mol Biochem Parasitol; 1989 Mar; 33(2):123-34. PubMed ID: 2542790
[TBL] [Abstract][Full Text] [Related]
17. Biochemical basis for the activity and selectivity of oral antifungal drugs.
Vanden Bossche H; Marichal P; Gorrens J; Coene MC
Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
[TBL] [Abstract][Full Text] [Related]
18. Biochemical approaches to selective antifungal activity. Focus on azole antifungals.
Vanden Bossche H; Marichal P; Gorrens J; Coene MC; Willemsens G; Bellens D; Roels I; Moereels H; Janssen PA
Mycoses; 1989; 32 Suppl 1():35-52. PubMed ID: 2561184
[TBL] [Abstract][Full Text] [Related]
19. [In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
Yamaguchi H; Ikeda F; Iyoda T; Suzuki M; Mikawa T
Med Mycol J; 2014; 55(4):J157-63. PubMed ID: 25742996
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of potential inhibitors of the ergosterol biosynthesis as antifungal agents.
Chung SK; Lee KW; Kang HI; Yamashita C; Kudo M; Yoshida Y
Bioorg Med Chem; 2000 Oct; 8(10):2475-86. PubMed ID: 11058043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
